|
HY-140499-100mg
|
MedChemexpress LLC
|
m-PEG9-acid [CAS 2576495-35-5]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-10mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-100mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-25mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-5mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-119464-50mg
|
MedChemexpress LLC
|
MRL-871 [CAS 1392809-08-3]
|
|
Cancer-programmed cell death
|
|
|
HY-139402-1mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139402-10mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139402-100mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139402-25mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139402-5mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139402-50mg
|
MedChemexpress LLC
|
MRTX849 acid [CAS 2561529-96-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-W053507-500mg
|
MedChemexpress LLC
|
m-Tolylacetic acid [CAS 621-36-3]
|
|
|
|
|
HY-W053507-1mL
|
MedChemexpress LLC
|
m-Tolylacetic acid [CAS 621-36-3] (10mM in DMSO)
|
|
|
|
|
HY-P0280-1mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0280-10mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-P0280-5mg
|
MedChemexpress LLC
|
Mu C5AC motif peptide [CAS 244049-41-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-W014410-1g
|
MedChemexpress LLC
|
Mu cic acid [CAS 526-99-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-W014410-5g
|
MedChemexpress LLC
|
Mu cic acid [CAS 526-99-8]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-D1542-1g
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-D1542-5g
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-D1542-500mg
|
MedChemexpress LLC
|
Mu cicarmine [CAS 51395-97-2]
|
|
|
|
|
HY-113247S1-500ug
|
MedChemexpress LLC
|
Mu conic acid-d4 [CAS 1185239-59-1]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-N5031-1mg
|
MedChemexpress LLC
|
Mu lberrofuran Q [CAS 101383-35-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-N5031-10mg
|
MedChemexpress LLC
|
Mu lberrofuran Q [CAS 101383-35-1]
|
|
COVID-19-immunoregulation
|
|
